価格表

在庫・価格 : 2026年03月16日 00時23分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
DreamFect Gold
データシート
DG81000 OZBオズ バイオサイエンス
OZ Biosciences
1 ml ¥115,000
(未発注)
追加

在庫・価格 : 2026年03月16日 00時23分 現在

DreamFect Gold

  • 商品コード:DG81000
  • メーカー:OZB
  • 包装:1ml
  • 価格: ¥115,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 O. Markova, et al. J Neurosci Meth (2007), doi:10.1016/2007.12.016

Cell Line : CHO, Origin/Description : Ovary, Type : Hamster PubMed
2 HA. Krol, et al. PLoS ONE. 2008 Jan 30;3(1):e1503.

Cell Line : SH-SY5Y, Origin/Description : Neuroblastoma, Type : Human PubMed
3 Krol HA et al. Polyglutamine expansion accelerates the dynamics of ataxin-1 and does not result in aggregate formation. PLoS ONE 2008;3(1):e1503
Krol HA et al
2008/01/01
PubMed
4 Markova O et al. Genetically encoded chloride indicator with improved sensitivity. J. Neurosci. Methods 2008 May;170(1):67-76
Markova O et al
2008/01/01
PubMed
5 Cao L et al. Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis 2008 Oct;29(10):1893-900
Cao L et al
2008/01/01
PubMed
6 Falkenhagen A et al. Short hairpin-loop-structured oligodeoxynucleotides reduce HSV-1 replication. Virol. J. 2009 Apr;6:43
Falkenhagen A et al
2009/01/01
PubMed
7 Noreen F et al. Antitumor activity of small double-stranded oligodeoxynucleotides targeting telomerase RNA in malignant melanoma cells. Oligonucleotides 2009 Jun;19(2):169-78
Noreen F et al
2009/01/01
PubMed
8 Colombo M et al. The interaction between the measles virus nucleoprotein and the Interferon Regulator Factor 3 relies on a specific cellular environment. Virol. J. 2009 May;6:59
Colombo M et al
2009/01/01
PubMed
9 Shao M et al. Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Res. 2009 Dec;69(24):9192-201
Shao M et al
2009/01/01
PubMed
10 Zhang Y et al. Amino acid deprivation induces CREBZF/Zhangfei expression via an AARE-like element in the promoter. Biochem. Biophys. Res. Commun. 2010 Jan;391(3):1352-7
Zhang Y et al
2010/01/01
PubMed
11 Sharir H et al. Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair. J. Biol. Chem. 2010 Aug;285(34):26097-106
Sharir H et al
2010/01/01
PubMed
12 Miller EW et al. Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc. Natl. Acad. Sci. U.S.A. 2010 Sep;107(36):15681-6
Miller EW et al
2010/01/01
PubMed
13 Hayot M et al. Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli. Mol. Cell. Endocrinol. 2011 Jan;332(1-2):38-47
Hayot M et al
2011/01/01
PubMed
14 Ishdorj G et al. Inhibition of constitutive activation of STAT3 by curcurbitacin-I (JSI-124) sensitized human B-leukemia cells to apoptosis. Mol. Cancer Ther. 2010 Dec;9(12):3302-14
Ishdorj G et al
2010/01/01
PubMed
15 Bernardi H et al. Wnt4 activates the canonical β-catenin pathway and regulates negatively myostatin: functional implication in myogenesis. Am. J. Physiol., Cell Physiol. 2011 May;300(5):C1122-38
Bernardi H et al
2011/01/01
PubMed
16 Tichy ED et al. Mismatch and base excision repair proficiency in murine embryonic stem cells. DNA Repair (Amst.) 2011 Apr;10(4):445-51
Tichy ED et al
2011/01/01
PubMed
17 Heiligenstein S et al. Evaluation of nonbiomedical and biomedical grade alginates for the transplantation of genetically modified articular chondrocytes to cartilage defects in a large animal model in vivo. J Gene Med 2011 Apr;13(4):230-42
Heiligenstein S et al
2011/01/01
PubMed
18 Horodyski FM et al. Isolation and functional characterization of an allatotropin receptor from Manduca sexta. Insect Biochem. Mol. Biol. 2011 Oct;41(10):804-14
Horodyski FM et al
2011/01/01
PubMed
19 Zheng Y et al. Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site. Int. J. Biochem. Cell Biol. 2011 Nov;43(11):1641-8
Zheng Y et al
2011/01/01
PubMed
20 Mukherji S et al. MicroRNAs can generate thresholds in target gene expression. Nat. Genet. 2011 Aug;43(9):854-9
Mukherji S et al
2011/01/01
PubMed
21 Lopez-Mejia IC et al. A conserved splicing mechanism of the LMNA gene controls premature aging. Hum. Mol. Genet. 2011 Dec;20(23):4540-55
Lopez-Mejia IC et al
2011/01/01
PubMed
22 Gobbo J et al. Quantification of HSP27 and HSP70 molecular chaperone activities. Methods Mol. Biol. 2011;787:137-43
Gobbo J et al
2011/01/01
PubMed
23 Cao L et al. Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene 2012 May;31(20):2521-34
Cao L et al
2012/01/01
PubMed
24 Burnett HF et al. Herpes simplex virus-1 disarms the unfolded protein response in the early stages of infection. Cell Stress Chaperones 2012 Jul;17(4):473-83
Burnett HF et al
2012/01/01
PubMed
25 Butt AQ et al. 14-3-3ε and 14-3-3σ inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction. J. Biol. Chem. 2012 Nov;287(46):38665-79
Butt AQ et al
2012/01/01
PubMed
26 Ahmed S et al. TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15. J. Immunol. 2013 Mar;190(5):2217-28
Ahmed S et al
2013/01/01
PubMed
27 Breig O et al. Proteasome-mediated proteolysis of SRSF5 splicing factor intriguingly co-occurs with SRSF5 mRNA upregulation during late erythroid differentiation. PLoS ONE 2013;8(3):e59137
Breig O et al
2013/01/01
PubMed
28 Condello S et al. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism. FASEB J. 2013 Aug;27(8):3100-12
Condello S et al
2013/01/01
PubMed
29 Ozawa K et al. S-nitrosylation regulates mitochondrial quality control via activation of parkin. Sci Rep 2013;3:2202
Ozawa K et al
2013/01/01
PubMed
30 Nabatov AA et al. Hypoxia inducible NOD2 interacts with 3-O-sulfogalactoceramide and regulates vesicular homeostasis. Biochim. Biophys. Acta 2013 Jul;1830(11):5277-5286
Nabatov AA et al
2013/01/01
PubMed
31 Breig O et al. Combined inhibition of PI3K and activation of MAPK p38 signaling pathways trigger erythroid alternative splicing switch of 4.1R pre-mRNA in DMSO-induced erythroleukemia cells. Cell. Signal. 2013 Dec;25(12):2453-61
Breig O et al
2013/01/01
PubMed
32 Kr鱈z V et al. β-arrestin promotes Wnt-induced low density lipoprotein receptor-related protein 6 (Lrp6) phosphorylation via increased membrane recruitment of Amer1 protein. J. Biol. Chem. 2014 Jan;289(2):1128-41
Kr鱈z V et al
2014/01/01
PubMed
33 Butt AQ et al. WITHDRAWN: Modulation of TLR3, TLR4 and TLR7 mediated IFN-β, Rantes and TNFα production by HIVEP1. J. Biol. Chem. 2014 Apr;
Butt AQ et al
2014/01/01
PubMed
34 Vafiadaki E et al. Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation. FEBS J. 2014 Jul;281(14):3261-79
Vafiadaki E et al
2014/01/01
PubMed
35 Mardilovich K et al. Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation. Mol. Cancer Ther. 2015 Jan;14(1):246-58
Mardilovich K et al
2015/01/01
PubMed
36 Lento S et al. Proteomics of tissue factor silencing in cardiomyocytic cells reveals a new role for this coagulation factor in splicing machinery control. J Proteomics 2015 Apr;119:75-89
Lento S et al
2015/01/01
PubMed
37 Baetta R et al. Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation. Vascul. Pharmacol. ;67-69:38-47
Baetta R et al
PubMed
38 Miller BW et al. Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy. EMBO Mol Med 2015 Aug;7(8):1063-76
Miller BW et al
2015/01/01
PubMed
39 Kalaidzidis I et al. APPL endosomes are not obligatory endocytic intermediates but act as stable cargo-sorting compartments. J. Cell Biol. 2015 Oct;211(1):123-44
Kalaidzidis I et al
2015/01/01
PubMed
40 Velot L et al. Negative regulation of EB1 turnover at microtubule plus ends by interaction with microtubule-associated protein ATIP3. Oncotarget 2015 Dec;6(41):43557-70
Velot L et al
2015/01/01
PubMed
41 Filocamo G et al. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma. Mol. Cancer Ther. 2016 Jun;15(6):1177-89
Filocamo G et al
2016/01/01
PubMed
42 Grzeナ嫐owiak BF et al. Generation of Transgenic Porcine Fibroblast Cell Lines Using Nanomagnetic Gene Delivery Vectors. Mol. Biotechnol. 2016 May;58(5):351-61
Grzeナ嫐owiak BF et al
2016/01/01
PubMed
43 Tan PK et al. Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout. Mol. Biol. Evol. 2016 Sep;33(9):2193-200
Tan PK et al
2016/01/01
PubMed
44 de Leon M et al. Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer. Gynecol. Oncol. 2016 Sep;142(3):539-47
de Leon M et al
2016/01/01
PubMed
45 Czugala M et al. Efficient and safe gene delivery to human corneal endothelium using magnetic nanoparticles. Nanomedicine (Lond) 2016 Jul;11(14):1787-800
Czugala M et al
2016/01/01
PubMed
46 Li C et al. Unravelling the Mechanism of TrkA-Induced Cell Death by Macropinocytosis in Medulloblastoma Daoy Cells. Mol. Cell. Biol. 2016 Oct;36(20):2596-611
Li C et al
2016/01/01
PubMed
47 Miner J et al. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney. Arthritis Res. Ther. 2016 Oct;18(1):214
Miner J et al
2016/01/01
PubMed
48 Koh W et al. Dynamic ASXL1 Exon Skipping and Alternative Circular Splicing in Single Human Cells. PLoS ONE 2016;11(10):e0164085
Koh W et al
2016/01/01
PubMed
49 Rogers A, Thesis Dissertation, 2013, University of Nebraska - Lincoln

PubMed
50 Sanchez-Antequera Y., Int. J. Biomed. Nano. 2010.

PubMed
51 Terenzion M.,Front. Cell. Neurosci., 20 May 2014

PubMed
52 Sanchez-Antequera Y., Hum Gene Therapy 2007; 18:994-1092.

PubMed
53 Cerda B., RSC Adv., 2015,DOI: 10.1039/C5RA06562C

PubMed
54 Sarkar K., RSC Adv., 2015,5, 91619-91632

PubMed
55 Esler S., Eur Cells Mater. 2008; 16(4):68.

PubMed
56 Infante P., Cell Death and Disease (2016) 7, e2376; doi:10.1038/cddis.2016.195

PubMed
57 Hurley TD., Patent

PubMed
58 Balmayor ER., Biomaterials 2016, doi: 10.1016/j.biomaterials.2016.02.018

PubMed
59 Van Hiel MB., Peptides. 2014; DOI: 10.1016/j.peptides.2014.07.014

PubMed
60 Cardenas H., Epigenetics. 2014, in press

PubMed
61 Tlili S., Biophys J. 2016. arXiv:1610.05420

PubMed
62 Cao, Liyun., Thesis, Dpmt of Bioch& Mol Biol, Indiana Univ. 2012

PubMed
63 Cardenas H et al. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells. Oncotarget 2016 Dec;7(51):84453-84467
Cardenas H et al
2016/01/01
PubMed
64 Balmayor ER et al. Modified mRNA for BMP-2 in Combination with Biomaterials Serves as a Transcript-Activated Matrix for Effectively Inducing Osteogenic Pathways in Stem Cells. Stem Cells Dev. 2017 Jan;26(1):25-34
Balmayor ER et al
2017/01/01
PubMed
65 Ferizi M et al. Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts. Sci Rep 2016 Dec;6:39149
Ferizi M et al
2016/01/01
PubMed
66 Broecker F et al. The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation. Mob DNA 2016;7:25
Broecker F et al
2016/01/01
PubMed
67 Cerda MB et al. Silencing peroxiredoxin-2 sensitizes human colorectal cancer cells to ionizing radiation and oxaliplatin. Cancer Lett. 2017 Mar;388:312-319
Cerda MB et al
2017/01/01
PubMed
68 Li J et al. Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells. Cell Stem Cell 2017 Mar;20(3):303-314.e5
Li J et al
2017/01/01
PubMed
69 Alfonsi R et al. Design, Palladium-Catalyzed Synthesis, and Biological Investigation of 2-Substituted 3-Aroylquinolin-4(1H)-ones as Inhibitors of the Hedgehog Signaling Pathway. J. Med. Chem. 2017 Feb;60(4):1469-1477
Alfonsi R et al
2017/01/01
PubMed
70 Scudiero I et al. CARMA2sh and ULK2 control pathogen-associated molecular patterns recognition in human keratinocytes: psoriasis-linked CARMA2sh mutants escape ULK2 censorship. Cell Death Dis 2017 Feb;8(2):e2627
Scudiero I et al
2017/01/01
PubMed
71 Tan PK et al. Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout. Sci Rep 2017 Apr;7(1):665
Tan PK et al
2017/01/01
PubMed
72 Laugier L et al. Whole genome Cardiac DNA methylation fingerprint and gene expression analysis provide new insights in the pathogenesis of Chronic Chagas disease Cardiomyopathy. Clin. Infect. Dis. 2017 May;
Laugier L et al
2017/01/01
PubMed
73 Lapp H et al. Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes. Sci Rep 2017 Aug;7(1):9629
Lapp H et al
2017/01/01
PubMed
74 Arvanitis DA et al. Muscle Lim Protein and myosin binding protein C form a complex regulating muscle differentiation. Biochim. Biophys. Acta 2017 Dec;1864(12):2308-2321
Arvanitis DA et al
2017/01/01
PubMed
75 Cerda B., RSC Adv., 2015,DOI: 10.1039/C5RA06562C

PubMed
76 O'Neill S et al. Quantitative interaction analysis permits molecular insights into functional NOX4 NADPH oxidase heterodimer assembly. J. Biol. Chem. 2018 Jun;293(23):8750-8760
O'Neill S et al
2018/01/01
PubMed
77 Infante P et al. Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis. Nat Commun 2018 03;9(1):976
Infante P et al
2018/01/01
PubMed
78 Infante P., Cell Death and Disease (2016) 7, e2376; doi:10.1038/cddis.2016.195

PubMed
79 Van Hiel MB., Peptides. 2014; DOI: 10.1016/j.peptides.2014.07.014

PubMed
80 Borgo C., 2018. BBA. 1862(12), Pages 2902-2910

PubMed
81 Marziali F et al. Interference of HTLV-1 Tax Protein with Cell Polarity Regulators: Defining the Subcellular Localization of the Tax-DLG1 Interaction. Viruses 2017 11;9(12)
Marziali F et al
2017/01/01
PubMed
82 Tlili S., Royal Society Open Science doi: 10.1098/rsos.172421

PubMed
83 Berardozzi S et al. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold. Eur J Med Chem 2018 Aug;156:554-562
Berardozzi S et al
2018/01/01
PubMed
84 Krol HAG., 2016 UvA-DARE

PubMed
85 Cardenas H., Epigenetics. 2014, in press

PubMed
86 Balmayor ER., Biomaterials 2016, doi: 10.1016/j.biomaterials.2016.02.018

PubMed
87 Cohen PY., 2018. Mediator of Inflammation Apr18

PubMed
88 Telesio G et al. The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling. Int J Mol Sci 2017 Dec;18(12)
Telesio G et al
2017/01/01
PubMed
89 Rogers A, Thesis Dissertation, 2013, University of Nebraska - Lincoln

PubMed
90 Balmayor ER., Biomaterials 2016, doi: 10.1016/j.biomaterials.2016.02.018

PubMed
91 Cerda B., RSC Adv., 2015,DOI: 10.1039/C5RA06562C

PubMed
92 Hasenpusch G., Patent 0381193

PubMed
93 Felicio D., Sci Rep. 2025 Dec 21;16(1):2501.

PubMed
94 Navacci S., Thesis 2025 - U Roma

PubMed
95 Kumar A., iScience 2024 doi.org/10.1016/j.isci.2024.109994

PubMed
96 Chiu CF., Biomolecules 2021, 11(3), 370; https://doi.org/10.3390/biom11030370

PubMed
97 Mendez AMZ, 2020, Thesis

PubMed
98 Klingbeil, J., 2020. Thesis

PubMed
99 Chen LY., J Invest Dermatol., 2019 doi.org/10.1016/j.jid.2019.09.017

PubMed
100 Infante P., Cell Death and Disease (2016) 7, e2376; doi:10.1038/cddis.2016.195

PubMed
101 Van Hiel MB., Peptides. 2014; DOI: 10.1016/j.peptides.2014.07.014

PubMed
102 Wohlfromm F., Thesis 2024 dx.doi.org/10.25673/117143

PubMed
103 Ueno Y., Tissue Barriers 2019, Mar. doi.org/10.1080/21688370.2019.1593775

PubMed
104 Hurley TD., Patent

PubMed
105 Sanchez-Antequera Y., Hum Gene Therapy 2007; 18:994-1092.

PubMed
106 Pontecorvi P., Biology 2021, 10(6), 450; https://doi.org/10.3390/biology10060450

PubMed
107 Wu X., bioRxiv 2025 doi.org/10.1101/2025.11.18.689080

PubMed
108 Chang CW., Int. J. Mol. Sci. 2025, 26(13), 5931

PubMed
109 Readler JM., MethodsX. 2020. doi.org/10.1016/j.mex.2020.101149

PubMed
110 Readler JM., Virology 2019. https://doi.org/10.1016/j.virol.2019.07.018

PubMed
111 Bufalieri F., Mol Ther. 2026 Jan 7;34(1):582-605

PubMed
112 Terenzion M.,Front. Cell. Neurosci., 20 May 2014

PubMed
113 Magalh邯殱 J., Cell Rep. 2025 Oct 28;44(10):116411.

PubMed
114 Krol HAG., 2016 UvA-DARE

PubMed
115 Cardenas H., Epigenetics. 2014, in press

PubMed
116 Angrisani A et al. Specific Protein 1 and p53 Interplay Modulates the Expression of the KCTD-Containing Cullin3 Adaptor Suppressor of Hedgehog 2. Front Cell Dev Biol 2021;9:638508
Angrisani A et al
2021/01/01
PubMed
117 Tun巽 CU et al. Silencing Breast Cancer Genes Using Morpholino Embedded DNA-Tile-AuNPs Nanostructures. Hum Gene Ther 2019 Dec;30(12):1547-1558
Tun巽 CU et al
2019/01/01
PubMed
118 Miele R et al. Physical TRPV1-PKR2 interaction modulates PKR2 localization, activation and β-arrestin-2 recruitment. Cell Signal 2025 Jul;131:111761
Miele R et al
2025/01/01
PubMed
119 Weinstein-Marom H et al. MHC-I presentation of peptides derived from intact protein products of the pioneer round of translation. FASEB J 2019 Oct;33(10):11458-11468
Weinstein-Marom H et al
2019/01/01
PubMed
120 Mariano A et al. Molecular Basis of Intron Retention in <i>PI-PLC &#x3B3;1</i> mRNA from Osteoarthritis Synoviocytes. Int J Mol Sci 2025 Aug;26(17)
Mariano A et al
2025/01/01
PubMed
121 Mariano A et al. Intron retention in PI-PLC &#x3B3;1 mRNA as a key mechanism affecting MMP expression in human primary fibroblast-like synovial cells. Cell Biochem Funct 2024 Jul;42(5):e4091
Mariano A et al
2024/01/01
PubMed
122 O&#39;Neill S et al. Protein-Protein Interaction Assay to Analyze NOX4/p22<sup>phox</sup> Heterodimerization. Methods Mol Biol 2019;1982:447-458
O&#39;Neill S et al
2019/01/01
PubMed
123 Puxeddu M et al. Development of <i>N</i>-(4-(1<i>H</i>-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of &#x3B2;-Catenin with Enhanced Antitumor Activity and Metabolic Stability. J Med Chem 2024 Nov;67(22):20298-20314
Puxeddu M et al
2024/01/01
PubMed
124 Nalli M et al. Novel <i>N</i>-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the &#x3B2;-Catenin Armadillo Repeats Domain as an Anticancer Agent. ACS Pharmacol Transl Sci 2023 Jul;6(7):1087-1103
Nalli M et al
2023/01/01
PubMed
125 Magalh達es J et al. Rac1 inhibition prevents axonal cytoskeleton dysfunction in transthyretin amyloid polyneuropathy. Cell Rep 2025 Oct;44(10):116411
Magalh達es J et al
2025/01/01
PubMed
126 Bordin F et al. SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation. Cell Death Discov 2024 Dec;10(1):498
Bordin F et al
2024/01/01
PubMed
127 Ambrosini G et al. Biochemical investigation of pathogenic missense mutations of human 4-amino butyrate aminotransferase towards the understanding of the molecular pathogenesis of GABA transaminase deficiency. Mol Genet Metab 2025 Jul;145(3):109149
Ambrosini G et al
2025/01/01
PubMed
128 Radi A et al. MAGED2 Enhances Expression and Function of NCC at the Cell Surface via cAMP Signaling Under Hypoxia. Cells 2025 Jan;14(3)
Radi A et al
2025/01/01
PubMed
129 Christoffers S et al. Blue Light-Induced, Dosed Protein Expression of Active BDNF in Human Cells Using the Optogenetic CRY2/CIB System. Biotechnol J 2024 Dec;19(12):e202400384
Christoffers S et al
2024/01/01
PubMed
130 Sajadi MM et al. A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV. Structure 2025 Jul;33(7):1150-1164.e8
Sajadi MM et al
2025/01/01
PubMed
131 Masci D et al. 4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1<i>H</i>-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/&#x3B2;-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells. J
Masci D et al
2023/01/01
PubMed
132 Fel鱈cio D et al. Non-coding variants in VAMP2 and SNAP25 affect gene expression: potential implications in migraine susceptibility. J Headache Pain 2023 Jun;24(1):78
Fel鱈cio D et al
2023/01/01
PubMed
133 Kumar A et al. MFN2 coordinates mitochondria motility with &#x3B1;-tubulin acetylation and this regulation is disrupted in CMT2A. iScience 2024 Jun;27(6):109994
Kumar A et al
2024/01/01
PubMed
134 Z叩rate AM et al. A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo. Int J Mol Sci 2021 Aug;22(16)
Z叩rate AM et al
2021/01/01
PubMed
135 Bufalieri F et al. The RNA-Binding Ubiquitin Ligase MEX3A Affects Glioblastoma Tumorigenesis by Inducing Ubiquitylation and Degradation of RIG-I. Cancers (Basel) 2020 Jan;12(2)
Bufalieri F et al
2020/01/01
PubMed
136 Schwob A et al. SQSTM-1/p62 potentiates HTLV-1 Tax-mediated NF-&#x3BA;B activation through its ubiquitin binding function. Sci Rep 2019 Nov;9(1):16014
Schwob A et al
2019/01/01
PubMed
137 Ivanisenko NV et al. Oligomerised RIPK1 is the main core component of the CD95 necrosome. EMBO J 2025 Jun;44(11):3231-3265
Ivanisenko NV et al
2025/01/01
PubMed
138 Wohlfromm F et al. Arginine methylation of caspase-8 controls life/death decisions in extrinsic apoptotic networks. Oncogene 2024 Jun;43(25):1955-1971
Wohlfromm F et al
2024/01/01
PubMed
139 K旦nig C et al. Targeting type I DED interactions at the DED filament serves as a sensitive switch for cell fate decisions. Cell Chem Biol 2024 Nov;31(11):1969-1985.e6
K旦nig C et al
2024/01/01
PubMed
140 Quiniou G et al. Impaired reprogramming of the autophagy flux in maturing dendritic cells from crohn disease patients with core autophagy gene-related polymorphisms. Autophagy 2024 Aug;20(8):1837-1853
Quiniou G et al
2024/01/01
PubMed
141 Claviere M et al. Measles virus-imposed remodeling of the autophagy machinery determines the outcome of bacterial coinfection. Autophagy 2023 Mar;19(3):858-872
Claviere M et al
2023/01/01
PubMed
142 Condello S et al. &#x3B2;-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids. Oncogene 2015 Apr;34(18):2297-308
Condello S et al
2015/01/01
PubMed
143 Kumamoto T et al. Direct Readout of Neural Stem Cell Transgenesis with an Integration-Coupled Gene Expression Switch. Neuron 2020 Aug;107(4):617-630.e6
Kumamoto T et al
2020/01/01
PubMed
144 . ;

PubMed
145 Mazzone P et al. UBAC1/KPC2 Regulates TLR3 Signaling in Human Keratinocytes through Functional Interaction with the CARD14/CARMA2sh-TANK Complex. Int J Mol Sci 2020 Dec;21(24)
Mazzone P et al
2020/01/01
PubMed
146 Yin K et al. Mitophagy protein PINK1 suppresses colon tumor growth by metabolic reprogramming via p53 activation and reducing acetyl-CoA production. Cell Death Differ 2021 Aug;28(8):2421-2435
Yin K et al
2021/01/01
PubMed
147 Kumar A et al. MFN2-dependent recruitment of ATAT1 coordinates mitochondria motility with alpha-tubulin acetylation and is disrupted in CMT2A. bioRxiv 2023 Mar;
Kumar A et al
2023/01/01
PubMed
148 Bufalieri F et al. ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of &#x3B2;TrCP. Nat Commun 2019 Jul;10(1):3304
Bufalieri F et al
2019/01/01
PubMed
149 Mariano A et al. Split Gp41-1 intein splicing as a model to evaluate the cellular location of the oncosuppressor Maspin in an in vitro model of osteosarcoma. Cell Biochem Funct 2024 Mar;42(2):e3987
Mariano A et al
2024/01/01
PubMed
150 Lospinoso Severini L et al. A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth. Cancers (Basel) 2019 Oct;11(10)
Lospinoso Severini L et al
2019/01/01
PubMed
151 Maroli A et al. Effect of donepezil on the expression and responsiveness to LPS of CHRNA7 and CHRFAM7A in macrophages: A possible link to the cholinergic anti-inflammatory pathway. J Neuroimmunol 2019 Jul;332:155-166
Maroli A et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    O. Markova, et al. J Neurosci Meth (2007), doi:10.1016/2007.12.016

  • 備考:
    Cell Line : CHO, Origin/Description : Ovary, Type : Hamster
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    HA. Krol, et al. PLoS ONE. 2008 Jan 30;3(1):e1503.

  • 備考:
    Cell Line : SH-SY5Y, Origin/Description : Neuroblastoma, Type : Human
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Krol HA et al. Polyglutamine expansion accelerates the dynamics of ataxin-1 and does not result in aggregate formation. PLoS ONE 2008;3(1):e1503
    Krol HA et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Markova O et al. Genetically encoded chloride indicator with improved sensitivity. J. Neurosci. Methods 2008 May;170(1):67-76
    Markova O et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Cao L et al. Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis 2008 Oct;29(10):1893-900
    Cao L et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Falkenhagen A et al. Short hairpin-loop-structured oligodeoxynucleotides reduce HSV-1 replication. Virol. J. 2009 Apr;6:43
    Falkenhagen A et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Noreen F et al. Antitumor activity of small double-stranded oligodeoxynucleotides targeting telomerase RNA in malignant melanoma cells. Oligonucleotides 2009 Jun;19(2):169-78
    Noreen F et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Colombo M et al. The interaction between the measles virus nucleoprotein and the Interferon Regulator Factor 3 relies on a specific cellular environment. Virol. J. 2009 May;6:59
    Colombo M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Shao M et al. Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Res. 2009 Dec;69(24):9192-201
    Shao M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Zhang Y et al. Amino acid deprivation induces CREBZF/Zhangfei expression via an AARE-like element in the promoter. Biochem. Biophys. Res. Commun. 2010 Jan;391(3):1352-7
    Zhang Y et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Sharir H et al. Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair. J. Biol. Chem. 2010 Aug;285(34):26097-106
    Sharir H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Miller EW et al. Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc. Natl. Acad. Sci. U.S.A. 2010 Sep;107(36):15681-6
    Miller EW et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Hayot M et al. Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli. Mol. Cell. Endocrinol. 2011 Jan;332(1-2):38-47
    Hayot M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Ishdorj G et al. Inhibition of constitutive activation of STAT3 by curcurbitacin-I (JSI-124) sensitized human B-leukemia cells to apoptosis. Mol. Cancer Ther. 2010 Dec;9(12):3302-14
    Ishdorj G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Bernardi H et al. Wnt4 activates the canonical &#x3B2;-catenin pathway and regulates negatively myostatin: functional implication in myogenesis. Am. J. Physiol., Cell Physiol. 2011 May;300(5):C1122-38
    Bernardi H et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Tichy ED et al. Mismatch and base excision repair proficiency in murine embryonic stem cells. DNA Repair (Amst.) 2011 Apr;10(4):445-51
    Tichy ED et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Heiligenstein S et al. Evaluation of nonbiomedical and biomedical grade alginates for the transplantation of genetically modified articular chondrocytes to cartilage defects in a large animal model in vivo. J Gene Med 2011 Apr;13(4):230-42
    Heiligenstein S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Horodyski FM et al. Isolation and functional characterization of an allatotropin receptor from Manduca sexta. Insect Biochem. Mol. Biol. 2011 Oct;41(10):804-14
    Horodyski FM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Zheng Y et al. Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site. Int. J. Biochem. Cell Biol. 2011 Nov;43(11):1641-8
    Zheng Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Mukherji S et al. MicroRNAs can generate thresholds in target gene expression. Nat. Genet. 2011 Aug;43(9):854-9
    Mukherji S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Lopez-Mejia IC et al. A conserved splicing mechanism of the LMNA gene controls premature aging. Hum. Mol. Genet. 2011 Dec;20(23):4540-55
    Lopez-Mejia IC et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Gobbo J et al. Quantification of HSP27 and HSP70 molecular chaperone activities. Methods Mol. Biol. 2011;787:137-43
    Gobbo J et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Cao L et al. Tissue transglutaminase links TGF-&#x3B2;, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene 2012 May;31(20):2521-34
    Cao L et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Burnett HF et al. Herpes simplex virus-1 disarms the unfolded protein response in the early stages of infection. Cell Stress Chaperones 2012 Jul;17(4):473-83
    Burnett HF et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Butt AQ et al. 14-3-3&#x3B5; and 14-3-3&#x3C3; inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction. J. Biol. Chem. 2012 Nov;287(46):38665-79
    Butt AQ et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Ahmed S et al. TRIF-mediated TLR3 and TLR4 signaling is negatively regulated by ADAM15. J. Immunol. 2013 Mar;190(5):2217-28
    Ahmed S et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Breig O et al. Proteasome-mediated proteolysis of SRSF5 splicing factor intriguingly co-occurs with SRSF5 mRNA upregulation during late erythroid differentiation. PLoS ONE 2013;8(3):e59137
    Breig O et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Condello S et al. Tissue transglutaminase regulates &#x3B2;-catenin signaling through a c-Src-dependent mechanism. FASEB J. 2013 Aug;27(8):3100-12
    Condello S et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Ozawa K et al. S-nitrosylation regulates mitochondrial quality control via activation of parkin. Sci Rep 2013;3:2202
    Ozawa K et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Nabatov AA et al. Hypoxia inducible NOD2 interacts with 3-O-sulfogalactoceramide and regulates vesicular homeostasis. Biochim. Biophys. Acta 2013 Jul;1830(11):5277-5286
    Nabatov AA et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Breig O et al. Combined inhibition of PI3K and activation of MAPK p38 signaling pathways trigger erythroid alternative splicing switch of 4.1R pre-mRNA in DMSO-induced erythroleukemia cells. Cell. Signal. 2013 Dec;25(12):2453-61
    Breig O et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Kr鱈z V et al. &#x3B2;-arrestin promotes Wnt-induced low density lipoprotein receptor-related protein 6 (Lrp6) phosphorylation via increased membrane recruitment of Amer1 protein. J. Biol. Chem. 2014 Jan;289(2):1128-41
    Kr鱈z V et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Butt AQ et al. WITHDRAWN: Modulation of TLR3, TLR4 and TLR7 mediated IFN-&#x3B2;, Rantes and TNF&#x3B1; production by HIVEP1. J. Biol. Chem. 2014 Apr;
    Butt AQ et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Vafiadaki E et al. Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation. FEBS J. 2014 Jul;281(14):3261-79
    Vafiadaki E et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Mardilovich K et al. Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation. Mol. Cancer Ther. 2015 Jan;14(1):246-58
    Mardilovich K et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Lento S et al. Proteomics of tissue factor silencing in cardiomyocytic cells reveals a new role for this coagulation factor in splicing machinery control. J Proteomics 2015 Apr;119:75-89
    Lento S et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Baetta R et al. Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation. Vascul. Pharmacol. ;67-69:38-47
    Baetta R et al
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Miller BW et al. Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy. EMBO Mol Med 2015 Aug;7(8):1063-76
    Miller BW et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Kalaidzidis I et al. APPL endosomes are not obligatory endocytic intermediates but act as stable cargo-sorting compartments. J. Cell Biol. 2015 Oct;211(1):123-44
    Kalaidzidis I et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Velot L et al. Negative regulation of EB1 turnover at microtubule plus ends by interaction with microtubule-associated protein ATIP3. Oncotarget 2015 Dec;6(41):43557-70
    Velot L et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Filocamo G et al. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma. Mol. Cancer Ther. 2016 Jun;15(6):1177-89
    Filocamo G et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Grzeナ嫐owiak BF et al. Generation of Transgenic Porcine Fibroblast Cell Lines Using Nanomagnetic Gene Delivery Vectors. Mol. Biotechnol. 2016 May;58(5):351-61
    Grzeナ嫐owiak BF et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Tan PK et al. Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout. Mol. Biol. Evol. 2016 Sep;33(9):2193-200
    Tan PK et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    de Leon M et al. Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer. Gynecol. Oncol. 2016 Sep;142(3):539-47
    de Leon M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Czugala M et al. Efficient and safe gene delivery to human corneal endothelium using magnetic nanoparticles. Nanomedicine (Lond) 2016 Jul;11(14):1787-800
    Czugala M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Li C et al. Unravelling the Mechanism of TrkA-Induced Cell Death by Macropinocytosis in Medulloblastoma Daoy Cells. Mol. Cell. Biol. 2016 Oct;36(20):2596-611
    Li C et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Miner J et al. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney. Arthritis Res. Ther. 2016 Oct;18(1):214
    Miner J et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Koh W et al. Dynamic ASXL1 Exon Skipping and Alternative Circular Splicing in Single Human Cells. PLoS ONE 2016;11(10):e0164085
    Koh W et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Rogers A, Thesis Dissertation, 2013, University of Nebraska - Lincoln

  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Sanchez-Antequera Y., Int. J. Biomed. Nano. 2010.

  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Terenzion M.,Front. Cell. Neurosci., 20 May 2014

  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Sanchez-Antequera Y., Hum Gene Therapy 2007; 18:994-1092.

  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Cerda B., RSC Adv., 2015,DOI: 10.1039/C5RA06562C

  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Sarkar K., RSC Adv., 2015,5, 91619-91632

  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Esler S., Eur Cells Mater. 2008; 16(4):68.

  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Infante P., Cell Death and Disease (2016) 7, e2376; doi:10.1038/cddis.2016.195

  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Hurley TD., Patent

  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Balmayor ER., Biomaterials 2016, doi: 10.1016/j.biomaterials.2016.02.018

  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Van Hiel MB., Peptides. 2014; DOI: 10.1016/j.peptides.2014.07.014

  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Cardenas H., Epigenetics. 2014, in press

  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Tlili S., Biophys J. 2016. arXiv:1610.05420

  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Cao, Liyun., Thesis, Dpmt of Bioch& Mol Biol, Indiana Univ. 2012

  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Cardenas H et al. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells. Oncotarget 2016 Dec;7(51):84453-84467
    Cardenas H et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Balmayor ER et al. Modified mRNA for BMP-2 in Combination with Biomaterials Serves as a Transcript-Activated Matrix for Effectively Inducing Osteogenic Pathways in Stem Cells. Stem Cells Dev. 2017 Jan;26(1):25-34
    Balmayor ER et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Ferizi M et al. Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts. Sci Rep 2016 Dec;6:39149
    Ferizi M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Broecker F et al. The intron-enriched HERV-K(HML-10) family suppresses apoptosis, an indicator of malignant transformation. Mob DNA 2016;7:25
    Broecker F et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Cerda MB et al. Silencing peroxiredoxin-2 sensitizes human colorectal cancer cells to ionizing radiation and oxaliplatin. Cancer Lett. 2017 Mar;388:312-319
    Cerda MB et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Li J et al. Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells. Cell Stem Cell 2017 Mar;20(3):303-314.e5
    Li J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Alfonsi R et al. Design, Palladium-Catalyzed Synthesis, and Biological Investigation of 2-Substituted 3-Aroylquinolin-4(1H)-ones as Inhibitors of the Hedgehog Signaling Pathway. J. Med. Chem. 2017 Feb;60(4):1469-1477
    Alfonsi R et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Scudiero I et al. CARMA2sh and ULK2 control pathogen-associated molecular patterns recognition in human keratinocytes: psoriasis-linked CARMA2sh mutants escape ULK2 censorship. Cell Death Dis 2017 Feb;8(2):e2627
    Scudiero I et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Tan PK et al. Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout. Sci Rep 2017 Apr;7(1):665
    Tan PK et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Laugier L et al. Whole genome Cardiac DNA methylation fingerprint and gene expression analysis provide new insights in the pathogenesis of Chronic Chagas disease Cardiomyopathy. Clin. Infect. Dis. 2017 May;
    Laugier L et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Lapp H et al. Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes. Sci Rep 2017 Aug;7(1):9629
    Lapp H et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Arvanitis DA et al. Muscle Lim Protein and myosin binding protein C form a complex regulating muscle differentiation. Biochim. Biophys. Acta 2017 Dec;1864(12):2308-2321
    Arvanitis DA et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Cerda B., RSC Adv., 2015,DOI: 10.1039/C5RA06562C

  • 備考:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    O&#39;Neill S et al. Quantitative interaction analysis permits molecular insights into functional NOX4 NADPH oxidase heterodimer assembly. J. Biol. Chem. 2018 Jun;293(23):8750-8760
    O&#39;Neill S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Infante P et al. Itch/&#x3B2;-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis. Nat Commun 2018 03;9(1):976
    Infante P et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Infante P., Cell Death and Disease (2016) 7, e2376; doi:10.1038/cddis.2016.195

  • 備考:
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Van Hiel MB., Peptides. 2014; DOI: 10.1016/j.peptides.2014.07.014

  • 備考:
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Borgo C., 2018. BBA. 1862(12), Pages 2902-2910

  • 備考:
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Marziali F et al. Interference of HTLV-1 Tax Protein with Cell Polarity Regulators: Defining the Subcellular Localization of the Tax-DLG1 Interaction. Viruses 2017 11;9(12)
    Marziali F et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Tlili S., Royal Society Open Science doi: 10.1098/rsos.172421

  • 備考:
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Berardozzi S et al. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold. Eur J Med Chem 2018 Aug;156:554-562
    Berardozzi S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Krol HAG., 2016 UvA-DARE

  • 備考:
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Cardenas H., Epigenetics. 2014, in press

  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Balmayor ER., Biomaterials 2016, doi: 10.1016/j.biomaterials.2016.02.018

  • 備考:
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Cohen PY., 2018. Mediator of Inflammation Apr18

  • 備考:
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Telesio G et al. The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling. Int J Mol Sci 2017 Dec;18(12)
    Telesio G et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Rogers A, Thesis Dissertation, 2013, University of Nebraska - Lincoln

  • 備考:
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Balmayor ER., Biomaterials 2016, doi: 10.1016/j.biomaterials.2016.02.018

  • 備考:
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Cerda B., RSC Adv., 2015,DOI: 10.1039/C5RA06562C

  • 備考:
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Hasenpusch G., Patent 0381193

  • 備考:
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Felicio D., Sci Rep. 2025 Dec 21;16(1):2501.

  • 備考:
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Navacci S., Thesis 2025 - U Roma

  • 備考:
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Kumar A., iScience 2024 doi.org/10.1016/j.isci.2024.109994

  • 備考:
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Chiu CF., Biomolecules 2021, 11(3), 370; https://doi.org/10.3390/biom11030370

  • 備考:
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Mendez AMZ, 2020, Thesis

  • 備考:
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Klingbeil, J., 2020. Thesis

  • 備考:
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Chen LY., J Invest Dermatol., 2019 doi.org/10.1016/j.jid.2019.09.017

  • 備考:
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Infante P., Cell Death and Disease (2016) 7, e2376; doi:10.1038/cddis.2016.195

  • 備考:
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Van Hiel MB., Peptides. 2014; DOI: 10.1016/j.peptides.2014.07.014

  • 備考:
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    Wohlfromm F., Thesis 2024 dx.doi.org/10.25673/117143

  • 備考:
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Ueno Y., Tissue Barriers 2019, Mar. doi.org/10.1080/21688370.2019.1593775

  • 備考:
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Hurley TD., Patent

  • 備考:
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Sanchez-Antequera Y., Hum Gene Therapy 2007; 18:994-1092.

  • 備考:
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Pontecorvi P., Biology 2021, 10(6), 450; https://doi.org/10.3390/biology10060450

  • 備考:
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Wu X., bioRxiv 2025 doi.org/10.1101/2025.11.18.689080

  • 備考:
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    Chang CW., Int. J. Mol. Sci. 2025, 26(13), 5931

  • 備考:
  • 参照:
    PubMed
  • No.: 109
  • 文献情報:
    Readler JM., MethodsX. 2020. doi.org/10.1016/j.mex.2020.101149

  • 備考:
  • 参照:
    PubMed
  • No.: 110
  • 文献情報:
    Readler JM., Virology 2019. https://doi.org/10.1016/j.virol.2019.07.018

  • 備考:
  • 参照:
    PubMed
  • No.: 111
  • 文献情報:
    Bufalieri F., Mol Ther. 2026 Jan 7;34(1):582-605

  • 備考:
  • 参照:
    PubMed
  • No.: 112
  • 文献情報:
    Terenzion M.,Front. Cell. Neurosci., 20 May 2014

  • 備考:
  • 参照:
    PubMed
  • No.: 113
  • 文献情報:
    Magalh邯殱 J., Cell Rep. 2025 Oct 28;44(10):116411.

  • 備考:
  • 参照:
    PubMed
  • No.: 114
  • 文献情報:
    Krol HAG., 2016 UvA-DARE

  • 備考:
  • 参照:
    PubMed
  • No.: 115
  • 文献情報:
    Cardenas H., Epigenetics. 2014, in press

  • 備考:
  • 参照:
    PubMed
  • No.: 116
  • 文献情報:
    Angrisani A et al. Specific Protein 1 and p53 Interplay Modulates the Expression of the KCTD-Containing Cullin3 Adaptor Suppressor of Hedgehog 2. Front Cell Dev Biol 2021;9:638508
    Angrisani A et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 117
  • 文献情報:
    Tun巽 CU et al. Silencing Breast Cancer Genes Using Morpholino Embedded DNA-Tile-AuNPs Nanostructures. Hum Gene Ther 2019 Dec;30(12):1547-1558
    Tun巽 CU et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 118
  • 文献情報:
    Miele R et al. Physical TRPV1-PKR2 interaction modulates PKR2 localization, activation and &#x3B2;-arrestin-2 recruitment. Cell Signal 2025 Jul;131:111761
    Miele R et al
    2025/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 119
  • 文献情報:
    Weinstein-Marom H et al. MHC-I presentation of peptides derived from intact protein products of the pioneer round of translation. FASEB J 2019 Oct;33(10):11458-11468
    Weinstein-Marom H et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 120
  • 文献情報:
    Mariano A et al. Molecular Basis of Intron Retention in <i>PI-PLC &#x3B3;1</i> mRNA from Osteoarthritis Synoviocytes. Int J Mol Sci 2025 Aug;26(17)
    Mariano A et al
    2025/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 121
  • 文献情報:
    Mariano A et al. Intron retention in PI-PLC &#x3B3;1 mRNA as a key mechanism affecting MMP expression in human primary fibroblast-like synovial cells. Cell Biochem Funct 2024 Jul;42(5):e4091
    Mariano A et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 122
  • 文献情報:
    O&#39;Neill S et al. Protein-Protein Interaction Assay to Analyze NOX4/p22<sup>phox</sup> Heterodimerization. Methods Mol Biol 2019;1982:447-458
    O&#39;Neill S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 123
  • 文献情報:
    Puxeddu M et al. Development of <i>N</i>-(4-(1<i>H</i>-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of &#x3B2;-Catenin with Enhanced Antitumor Activity and Metabolic Stability. J Med Chem 2024 Nov;67(22):20298-20314
    Puxeddu M et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 124
  • 文献情報:
    Nalli M et al. Novel <i>N</i>-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the &#x3B2;-Catenin Armadillo Repeats Domain as an Anticancer Agent. ACS Pharmacol Transl Sci 2023 Jul;6(7):1087-1103
    Nalli M et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 125
  • 文献情報:
    Magalh達es J et al. Rac1 inhibition prevents axonal cytoskeleton dysfunction in transthyretin amyloid polyneuropathy. Cell Rep 2025 Oct;44(10):116411
    Magalh達es J et al
    2025/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 126
  • 文献情報:
    Bordin F et al. SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation. Cell Death Discov 2024 Dec;10(1):498
    Bordin F et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 127
  • 文献情報:
    Ambrosini G et al. Biochemical investigation of pathogenic missense mutations of human 4-amino butyrate aminotransferase towards the understanding of the molecular pathogenesis of GABA transaminase deficiency. Mol Genet Metab 2025 Jul;145(3):109149
    Ambrosini G et al
    2025/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 128
  • 文献情報:
    Radi A et al. MAGED2 Enhances Expression and Function of NCC at the Cell Surface via cAMP Signaling Under Hypoxia. Cells 2025 Jan;14(3)
    Radi A et al
    2025/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 129
  • 文献情報:
    Christoffers S et al. Blue Light-Induced, Dosed Protein Expression of Active BDNF in Human Cells Using the Optogenetic CRY2/CIB System. Biotechnol J 2024 Dec;19(12):e202400384
    Christoffers S et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 130
  • 文献情報:
    Sajadi MM et al. A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV. Structure 2025 Jul;33(7):1150-1164.e8
    Sajadi MM et al
    2025/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 131
  • 文献情報:
    Masci D et al. 4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1<i>H</i>-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/&#x3B2;-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells. J
    Masci D et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 132
  • 文献情報:
    Fel鱈cio D et al. Non-coding variants in VAMP2 and SNAP25 affect gene expression: potential implications in migraine susceptibility. J Headache Pain 2023 Jun;24(1):78
    Fel鱈cio D et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 133
  • 文献情報:
    Kumar A et al. MFN2 coordinates mitochondria motility with &#x3B1;-tubulin acetylation and this regulation is disrupted in CMT2A. iScience 2024 Jun;27(6):109994
    Kumar A et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 134
  • 文献情報:
    Z叩rate AM et al. A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo. Int J Mol Sci 2021 Aug;22(16)
    Z叩rate AM et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 135
  • 文献情報:
    Bufalieri F et al. The RNA-Binding Ubiquitin Ligase MEX3A Affects Glioblastoma Tumorigenesis by Inducing Ubiquitylation and Degradation of RIG-I. Cancers (Basel) 2020 Jan;12(2)
    Bufalieri F et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 136
  • 文献情報:
    Schwob A et al. SQSTM-1/p62 potentiates HTLV-1 Tax-mediated NF-&#x3BA;B activation through its ubiquitin binding function. Sci Rep 2019 Nov;9(1):16014
    Schwob A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 137
  • 文献情報:
    Ivanisenko NV et al. Oligomerised RIPK1 is the main core component of the CD95 necrosome. EMBO J 2025 Jun;44(11):3231-3265
    Ivanisenko NV et al
    2025/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 138
  • 文献情報:
    Wohlfromm F et al. Arginine methylation of caspase-8 controls life/death decisions in extrinsic apoptotic networks. Oncogene 2024 Jun;43(25):1955-1971
    Wohlfromm F et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 139
  • 文献情報:
    K旦nig C et al. Targeting type I DED interactions at the DED filament serves as a sensitive switch for cell fate decisions. Cell Chem Biol 2024 Nov;31(11):1969-1985.e6
    K旦nig C et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 140
  • 文献情報:
    Quiniou G et al. Impaired reprogramming of the autophagy flux in maturing dendritic cells from crohn disease patients with core autophagy gene-related polymorphisms. Autophagy 2024 Aug;20(8):1837-1853
    Quiniou G et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 141
  • 文献情報:
    Claviere M et al. Measles virus-imposed remodeling of the autophagy machinery determines the outcome of bacterial coinfection. Autophagy 2023 Mar;19(3):858-872
    Claviere M et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 142
  • 文献情報:
    Condello S et al. &#x3B2;-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids. Oncogene 2015 Apr;34(18):2297-308
    Condello S et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 143
  • 文献情報:
    Kumamoto T et al. Direct Readout of Neural Stem Cell Transgenesis with an Integration-Coupled Gene Expression Switch. Neuron 2020 Aug;107(4):617-630.e6
    Kumamoto T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 144
  • 文献情報:
    . ;

  • 備考:
  • 参照:
    PubMed
  • No.: 145
  • 文献情報:
    Mazzone P et al. UBAC1/KPC2 Regulates TLR3 Signaling in Human Keratinocytes through Functional Interaction with the CARD14/CARMA2sh-TANK Complex. Int J Mol Sci 2020 Dec;21(24)
    Mazzone P et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 146
  • 文献情報:
    Yin K et al. Mitophagy protein PINK1 suppresses colon tumor growth by metabolic reprogramming via p53 activation and reducing acetyl-CoA production. Cell Death Differ 2021 Aug;28(8):2421-2435
    Yin K et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 147
  • 文献情報:
    Kumar A et al. MFN2-dependent recruitment of ATAT1 coordinates mitochondria motility with alpha-tubulin acetylation and is disrupted in CMT2A. bioRxiv 2023 Mar;
    Kumar A et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 148
  • 文献情報:
    Bufalieri F et al. ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of &#x3B2;TrCP. Nat Commun 2019 Jul;10(1):3304
    Bufalieri F et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 149
  • 文献情報:
    Mariano A et al. Split Gp41-1 intein splicing as a model to evaluate the cellular location of the oncosuppressor Maspin in an in vitro model of osteosarcoma. Cell Biochem Funct 2024 Mar;42(2):e3987
    Mariano A et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 150
  • 文献情報:
    Lospinoso Severini L et al. A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth. Cancers (Basel) 2019 Oct;11(10)
    Lospinoso Severini L et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 151
  • 文献情報:
    Maroli A et al. Effect of donepezil on the expression and responsiveness to LPS of CHRNA7 and CHRFAM7A in macrophages: A possible link to the cholinergic anti-inflammatory pathway. J Neuroimmunol 2019 Jul;332:155-166
    Maroli A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed